Antihemophilic factor human
Marken mit dem Wirkstoff Antihemophilic factor human, Lebensmittelhinweise und die wichtigsten Medikamenten-Wechselwirkungen.
MARKEN
38- ADVATE 1000 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONBarcode: 8681429550028
- ADVATE 1500 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONBarcode: 8681429550035
- ADVATE 2000 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONBarcode: 8681429550042
- ADVATE 250 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONBarcode: 8681429550004
- ADVATE 500 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONBarcode: 8681429550011
- ADYNOVATE 1000 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)Barcode: 8681429550509
- ADYNOVATE 1500 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)Barcode: 8681429550516
- ADYNOVATE 2000 IU/5ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)Barcode: 8681429550523
- ADYNOVATE 250 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)Barcode: 8681429550486
- ADYNOVATE 500 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)Barcode: 8681429550493
- BERIATE 1000 IU IV ENJEKSIYONLUK / INFUZYONLUK LIYOFILIZE TOZ VE COZUCUSUBarcode: 8681624980026
- BERIATE 500 IU IV ENJEKSIYONLUK / INFUZYONLUK LIYOFILIZE TOZ VE COZUCUSUBarcode: 8681624980019
- ELOCTA 1000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910038
- ELOCTA 1500 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910045
- ELOCTA 2000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910052
- ELOCTA 250 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910014
- ELOCTA 3000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910069
- ELOCTA 500 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU Barcode: 8683125910021
- EMOCLOT 1000 IU/10 ML IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8680972009038
- EMOCLOT 500 IU/10 ML IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8680972009021
- ESPEROCT 1000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)Barcode: 8699676791194
- ESPEROCT 1500 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)Barcode: 8699676791200
- ESPEROCT 2000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)Barcode: 8699676791217
- ESPEROCT 3000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)Barcode: 8699676791224
- ESPEROCT 500 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)Barcode: 8699676791187
- FANHDI 1000 IU 1 FLAKONBarcode: 8699769980078
- HAEMOCTIN SDH 500 IU / 10 ML IV ENJEKSIYONLUK TOZ VE COZUCU (1 FLAKON)Barcode: 8682109319829
- NOVOEIGHT 1000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8699676790678
- NOVOEIGHT 1500IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8699676790685
- NOVOEIGHT 2000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8699676790692
- NOVOEIGHT 3000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8699676790708
- NOVOEIGHT 500IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUBarcode: 8699676790661
- OCTANATE 1000 IU 1 FLAKONBarcode: 8699686980120
- OCTANATE 500 IU 1 FLAKONBarcode: 8699686980113
- REFACTO AF 1000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONBarcode: 8681308274427
- REFACTO AF 2000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONBarcode: 8681308274434
- REFACTO AF 250 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONBarcode: 8681308274403
- REFACTO AF 500 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONBarcode: 8681308274410
LEBENSMITTELHINWEISE
0Für diesen Wirkstoff liegen keine erfassten Lebensmittelhinweise vor.
WICHTIGSTE WECHSELWIRKUNGEN
erste 10 von 50Alpha-1-proteinase inhibitor kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Antihemophilic factor human.
- Aminocaproic acidMITTEL
Das Risiko oder die Schwere von Nebenwirkungen kann steigen, wenn Aminocaproic acid zusammen mit Antihemophilic factor human angewendet wird.
Expertenansicht
The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor human.
- Aminomethylbenzoic acidMITTEL
Aminomethylbenzoic acid kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor human.
- CamostatMITTEL
Camostat kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Camostat may increase the thrombogenic activities of Antihemophilic factor human.
- Menadione bisulfiteMITTEL
Menadione bisulfite kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Menadione bisulfite may increase the thrombogenic activities of Antihemophilic factor human.
- AprotininMITTEL
Aprotinin kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Aprotinin may increase the thrombogenic activities of Antihemophilic factor human.
- Hydrogen peroxideMITTEL
Hydrogen peroxide kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor human.
- MenadioneMITTEL
Menadione kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Menadione may increase the thrombogenic activities of Antihemophilic factor human.
- Tranexamic acidMITTEL
Tranexamic acid kann die thrombosefördernd (gerinnselbildend)-Aktivitäten von Antihemophilic factor human verstärken.
Expertenansicht
Tranexamic acid may increase the thrombogenic activities of Antihemophilic factor human.
- (R)-warfarinGERING
Die therapeutische Wirksamkeit von Antihemophilic factor human kann abnehmen, wenn es zusammen mit (R)-warfarin angewendet wird.
Expertenansicht
The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with (R)-warfarin.